GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rainmed Medical Ltd (HKSE:02297) » Definitions » EV-to-FCF

Rainmed Medical (HKSE:02297) EV-to-FCF : 0.72 (As of Sep. 21, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Rainmed Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Rainmed Medical's Enterprise Value is HK$-184.60 Mil. Rainmed Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-257.34 Mil. Therefore, Rainmed Medical's EV-to-FCF for today is 0.72.

The historical rank and industry rank for Rainmed Medical's EV-to-FCF or its related term are showing as below:

HKSE:02297' s EV-to-FCF Range Over the Past 10 Years
Min: -43.33   Med: -0.38   Max: 1.45
Current: 0.73

During the past 4 years, the highest EV-to-FCF of Rainmed Medical was 1.45. The lowest was -43.33. And the median was -0.38.

HKSE:02297's EV-to-FCF is ranked better than
92.84% of 363 companies
in the Medical Devices & Instruments industry
Industry Median: 28.12 vs HKSE:02297: 0.73

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-21), Rainmed Medical's stock price is HK$0.139. Rainmed Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.109. Therefore, Rainmed Medical's PE Ratio for today is At Loss.


Rainmed Medical EV-to-FCF Historical Data

The historical data trend for Rainmed Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rainmed Medical EV-to-FCF Chart

Rainmed Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -7.59 -0.63

Rainmed Medical Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial - -7.59 - -0.63 -

Competitive Comparison of Rainmed Medical's EV-to-FCF

For the Medical Devices subindustry, Rainmed Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rainmed Medical's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Rainmed Medical's EV-to-FCF falls into.



Rainmed Medical EV-to-FCF Calculation

Rainmed Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-184.596/-257.338
=0.72

Rainmed Medical's current Enterprise Value is HK$-184.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Rainmed Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-257.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rainmed Medical  (HKSE:02297) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Rainmed Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.139/-0.109
=At Loss

Rainmed Medical's share price for today is HK$0.139.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Rainmed Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.109.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Rainmed Medical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Rainmed Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Rainmed Medical Business Description

Traded in Other Exchanges
N/A
Address
No. 99, Jinji Lake Avenue, Building 31, Northeast District, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system are innovative medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD).
Executives
Huo Yunfei 2101 Beneficial owner
Zhou Bin
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si
Xi Zang Jing Jia Qi Ye Guan Li You Xian Ze Ren Gong Si
Shang Hai Jing Lin Gu Quan Tou Zi Guan Li You Xian Gong Si
Shang Hai Jing Wu Tou Zi Zhong Xin You Xian He Huo
Shang Hai Jing Mai Run Qi Ye Guan Li Zhong Xin You Xian He Huo
Gong Qing Cheng Jing Cheng Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Gong Qing Cheng Jing Lin Jing Jia Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Jing Lin Zi Ben Guan Li You Xian Gong Si
Shen Zhen Jing Lin Jing Ying Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Shen Zhen Jing Hui Gu Quan Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Shang Hai Tong Xiang Hao Qian Qi Ye Guan Li He Huo Qi Ye You Xian He Huo
Xi Zang Jing Ning Qi Ye Guan Li You Xian Ze Ren Gong Si
Liu Li Rui

Rainmed Medical Headlines

No Headlines